ArticleGynecologic oncology reports2025

Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study.

Tamaki Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.